Prism Medico and Pharmacy Limited (PRISMMEDI.BO)
INR 24.49
(3.73%)
INR 24.49
(3.73%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -121 Thousand | 29.54 Million | -23.78 Million | -514.76 Thousand | -43.64 Million | -12.32 Million |
| Net Income | -213 Thousand | -1.02 Million | -4.98 Million | -1.75 Million | -681.16 Thousand | 2.93 Million |
| Depreciation & Amortization | 52 Thousand | 66.03 Thousand | 86.6 Thousand | 123.97 Thousand | 176.18 Thousand | 266.99 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 93 Thousand | 3.66 Million | -18.89 Million | 1.11 Million | -42.83 Million | 88.59 Million |
| Other non-cash items | -10.97 Million | 26.83 Million | 4602.72 | 2464.68 | -304.81 Thousand | -104.12 Million |
| Investing Cash Flow | - | -29.13 Million | 23.5 Million | 241 Thousand | 43.59 Million | 12.49 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 19.38 Million | - | 80.61 Million | 12.49 Million |
| Other Investing Activities | - | -29.13 Million | 4.12 Million | 241 Thousand | -37.02 Million | - |
| Financing Cash Flow | -71 Thousand | -3254.00 | -4602.00 | -2465.00 | -2494.00 | 597.88 Thousand |
| Debt repayment | - | - | - | - | - | -5.63 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -71 Thousand | -3254.00 | -4602.00 | -2465.00 | -2494.00 | 6.22 Million |
| Accounts receivables | 10.71 Million | 1.19 Million | 86.33 Million | 48.22 Million | -99.99 Million | - |
| Accounts payables | 308 Thousand | - | -84.43 Million | -42.09 Thousand | 99.99 Million | - |
| Inventory | - | - | -19.23 Million | -47.99 Million | 9.13 Million | 760.74 Thousand |
| Other working capital | -10.93 Million | 2.47 Million | -1.54 Million | 921.52 Thousand | -51.97 Million | 87.83 Million |
| Cash at beginning of period | 957.35 Thousand | 551.02 Thousand | 841.32 Thousand | 1.11 Million | 1.17 Million | 401.94 Thousand |
| Cash at end of period | 836 Thousand | 957.35 Thousand | 551.02 Thousand | 841.32 Thousand | 1.11 Million | 1.17 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | -1.00 | -1.40 | -1.00 | -0.31 | - |
| Net cash flow / Change in cash | -121.35 Thousand | 406.32 Thousand | -290.3 Thousand | -276.22 Thousand | -58.26 Thousand | 773.87 Thousand |
| Free Cash Flow | -121 Thousand | 29.54 Million | -23.78 Million | -514.76 Thousand | -43.64 Million | -12.32 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -900 Thousand | -678 Thousand | -213 Thousand | 1.89 Million | -543 Thousand | -716.5 Thousand |
| Depreciation & Amortization | - | - | 52 Thousand | 13 Thousand | 13.5 Thousand | 13.5 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | 93 Thousand | - | 5.25 Million | 5.25 Million |
| Other non-cash items | 900 Thousand | 678 Thousand | -10.97 Million | -1.89 Million | 18.5 Thousand | 192 Thousand |
| Investing Cash Flow | - | - | - | - | -4.81 Million | -4.81 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | -4.81 Million | -4.81 Million |
| Financing Cash Flow | - | - | -71 Thousand | - | -500.00 | -500.00 |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | -71 Thousand | - | -500.00 | -500.00 |
| Accounts receivables | - | - | 10.71 Million | - | 5.54 Million | 5.54 Million |
| Accounts payables | - | - | 308 Thousand | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | -10.93 Million | - | -291 Thousand | -291 Thousand |
| Cash at beginning of period | - | - | 957.35 Thousand | - | - | 957.35 Thousand |
| Cash at end of period | - | - | 836 Thousand | 26 Thousand | -543 Thousand | -890 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | -462.5 Thousand | -809.5 Thousand |
| Net cash flow / Change in cash | - | - | -121.35 Thousand | 26 Thousand | -543 Thousand | -1.84 Million |
| Free Cash Flow | - | - | -121 Thousand | 26 Thousand | 4.73 Million | 4.73 Million |
ALODC
3292
2734
6277
5125
VOW